Anakinra reduces ventilation need, mortality in COVID-19

Anakinra reduces the need for mechanical ventilation as well as mortality among patients with severe COVID-19, and without serious side effects, according to data published in The Lancet Rheumatology.“SARS-CoV-2 is thought to bind to toll-like receptors, which activate the inflammasome and the cleavage of pro-IL-1 [beta] by caspase-1, followed by the production of active mature IL-1 [beta],

Read the full article here

Related Articles